Stories about research and scientific development at Mount Sinai
FREEDOM Trial Finds That High-Dose Anticoagulation Can Improve Survival for Hospitalized COVID-19 Patients
An international trial led by Mount Sinai found that high-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill, when compared to the standard treatment, which is low-dose...
Mount Sinai Experts Discuss the Future of Cancer Care and Research
More than 50 years after the United States formally declared war on cancer, what is the prognosis for innovative cancer research and care? Two Mount Sinai leaders in cancer care and research, Ramon Parsons, MD, PhD, Director of The Tisch Cancer Institute at the Icahn...
Using Insights From the Pandemic to Advance Research on Immunity in Down Syndrome
In April 2020, as the COVID-19 pandemic spread through New York City, Louise Malle, an MD/PhD candidate at the Icahn School of Medicine at Mount Sinai, turned her focus to the disturbing statistics coming out on disease severity. She thought the data might inform her...
Marla C. Dubinsky, MD, Receives 2022 Sherman Prize Recognizing Excellence in Inflammatory Bowel Disease
Marla C. Dubinsky, MD, an internationally recognized leader in pediatric inflammatory bowel disease (IBD), was one of three national recipients of the 2022 Sherman Prize. The award, which recognizes individuals for pioneering achievements that have transformed patient...
In Milestone Finding, ‘Polypill’ Reduces Cardiovascular Mortality by 33 Percent in Patients Treated After a Heart Attack
In a milestone in cardiovascular medicine, a three-drug medication known as a “polypill” was found effective in preventing adverse events such as heart attacks or stroke in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent...
Jennifer Chan, PhD, Receives Robin Chemers Neustein Postdoctoral Fellowship Award for Innovative Research
Jennifer Chan, PhD, whose work is vastly expanding knowledge about pregnancy, brain health, and stress, is the recipient of the 2022 Robin Chemers Neustein Postdoctoral Fellowship Award, established in 2010 to encourage and support female research scientists at the...
Epigenetic Disease in the HIV+ Brain: An Innovative Longitudinal Study Method
Most clinical studies benefit from taking repeated measurements over weeks, months, years. Researchers studying epigenetic disease processes in the brain don’t have that luxury. “You harvest the brain, and you only get one time point,” says Schahram Akbarian, MD, PhD,...
Non-Hispanic Blacks Found Twice as Likely to Have Atherosclerosis as Hispanics in Study of Young Adults in Harlem
A unique Mount Sinai study focused on a multiethnic, underserved community in Harlem found that young non-Hispanic Black adult participants were twice as likely to have atherosclerosis as young Hispanic adults. The research, published in the Journal of the American...
Computational Neuroscientist Opens Doors for New Ideas and Talent to Thrive
When Kanaka Rajan, PhD, an expert in neural networks, joined the Icahn School of Medicine at Mount Sinai in late 2018, it was the school’s way of investing in computational neuroscience. But since establishing her lab, she has achieved new heights not just in her area...